Insulin lispro Subcutaneous and Trastuzumab Injection (Intravenous)
Determining the interaction of Insulin lispro Subcutaneous and Trastuzumab Injection (Intravenous) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Trastuzumab Intravenous
- Insulin lispro Subcutaneous-Trastuzumab-anns
- Insulin lispro Subcutaneous-Trastuzumab-dkst
- Insulin lispro Subcutaneous-Trastuzumab-dkst Intravenous
- Insulin lispro Subcutaneous-Trasylol
- Insulin lispro Subcutaneous-Travasol
- Trastuzumab Injection (Intravenous)-Insulin NPH
- Trastuzumab Injection (Intravenous)-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Trastuzumab Injection (Intravenous)-Insulin NPH (Vials)
- Trastuzumab Injection (Intravenous)-Insulin NPH and Insulin Regular
- Trastuzumab Injection (Intravenous)-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Trastuzumab Injection (Intravenous)-Insulin NPH and Insulin Regular (Vials)